न्यूलँड प्रयोगशाळा शेअर किंमत

न्यूलँड लॅबोरेटरीज ही एक प्रमुख फार्मास्युटिकल कंपनी आहे जी सक्रिय फार्मास्युटिकल घटक (एपीआय) आणि कस्टम उत्पादन उपाय तयार करण्यात तज्ज्ञ आहे. हे कार्डिओव्हॅस्क्युलर आणि केंद्रीय मज्जासंस्था यासह गंभीर उपचारात्मक क्षेत्रांसाठी उच्च दर्जाच्या एपीआय असलेल्या जागतिक फार्मास्युटिकल कंपन्यांना सेवा प्रदान करते.

Neuland Laboratories has an operating revenue of Rs. 1,533.42 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 23% is great, ROE of 17% is exceptional. The company has a reasonable debt to equity of 6%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 25% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around 3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 66 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.

डिस्कलेमर: हा स्टॉक विश्लेषण रिपोर्ट केवळ माहितीपूर्ण हेतूंसाठी अल्गोरिदमली तयार केला जातो आणि खरेदी किंवा विक्री शिफारस म्हणून विचारात घेतला जाऊ नये.